Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Orexigen Therapeutic (NASDAQ: OREX)

$2.97 USD $0.03 (1.02%)
Last Price $2.97
Net Change $0.03 (1.02%)
Bid $0
Ask Price $0
Open Price $2.92
Previous Close Price $2.94
High Price $3.04
Low Price $2.89
Number of Trades 145
Volume 41,400
Fifty Two Week High $6.5 (2016-06-08)
Fifty Two Week Low $1.65 (2016-12-14)
Average Daily Volume 566,981
Share Outstanding 15,230 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-4.67 (2017-05-09)
2nd Quarter Earnings $-1.69 (2017-03-28)
3nd Quarter Earnings $1.12 (2016-11-03)
4th Quarter Earnings $-1.73 (2016-08-04)
PE Ratio $0
EPS Growth $-65.75
Recent Earnings $-4.67
Annual EPS $-10.08
Last Quarter EPS $
Market Capitalization $0.05B
Insider Shareholders % 0.137%
Annual Revenue $0B
No. Shares Outstanding 15,230
Inst. Shareholder % 45.12%
Annual Net Income $-0.07B
TTM Net Profit Margin $-149.04
1-Year Return -29.29%
3-Year Return -95.26%
5-Year Return -91.44%
5-Year Revenue Growth 666.14%
5-Year Earnings Growth 19.31%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -65.75%
Dividends per Share $
Stock Split Ratio 1-10
Beta 2.61
OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials, and Empatic, which is in the later stages of Phase II clinical development. Both product candidates are designed to take advantage of the Company's understanding of how the brain appears to regulate appetite and energy expenditure, as well as the mechanisms that come into play to limit weight loss over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss.